---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-003766"
form_type: "8-K"
ticker: "TMDX"
cik: "0001756262"
company_name: "TransMedics Group, Inc."
filed_at: "2023-02-22T23:59:59+00:00"
generated_at: "2026-06-19T05:12:20.739556+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# TransMedics Q4 revenue $31.4M (+225% YoY); guides FY2023 $138-145M

## Summary
- Total revenue $31.4M in Q4 2022, up 225% from $9.7M in Q4 2021; full-year revenue $93.5M (+209%).
- Net loss narrowed to $6.7M in Q4 2022 from $12.7M; full-year net loss $36.2M vs $44.2M in 2021.
- Gross margin 66% in Q4 vs 72% prior year; full-year gross margin flat at 70%.
- Cash and equivalents $201.2M as of Dec 31, 2022; operating expenses rose to $27.5M in Q4.
- FY2023 revenue guidance $138-145M (48-55% growth); appointed Nick Corcoran as SVP Supply Chain in Jan 2023.

## SEC filing metadata
- accession: 0000950170-23-003766
- form_type: 8-K
- ticker: TMDX
- cik: 0001756262
- company_name: TransMedics Group, Inc.
- filed_at: 2023-02-22T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1756262/000095017023003766/0000950170-23-003766-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1756262/000095017023003766/tmdx-20230222.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-003766
- JSON: https://secwatch.observer/filing/0000950170-23-003766.json
- Plain text: https://secwatch.observer/filing/0000950170-23-003766.txt

## Key facts
- Earnings Releases
  TransMedics Group, Inc. reported Full year 2023 results: revenue $138 million to $145 million. Guidance initiated.
  - Period: Full year 2023
  - Revenue: $138 million to $145 million
  - Guidance: initiated
  - Result: guidance update
  source text: TransMedics expects total revenue for full-year 2023 to be in the range of $138 million to $145 million, which represents 48% to 55% growth compared to the company’s prior year revenue.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1756262/000095017023003766/0000950170-23-003766-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.